Koers Pure Global Cannabis Inc Toronto S.E.
Aandelen
RSL
CA7806782073
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 32,87 mln. 22,2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,29 mln. -21,13 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 287K 194K | Nettoschuld 2018 | 4,49 mln. 6,11 mln. 4,13 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+45,15% | 6,34 mld. | |
-14,00% | 4,61 mld. | |
+9,54% | 3,39 mld. | |
-8,99% | 3,29 mld. | |
+50,03% | 2,02 mld. | |
-6,97% | 1,73 mld. | |
-0,31% | 1,67 mld. | |
+50,00% | 1,63 mld. | |
-10,61% | 1,59 mld. |